EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
CPHI Americas 2026: Where Strategic Partnerships, AI, and Advanced Manufacturing Are Shaping Pharma’s Future
CPHI Americas marks a fundamental shift in what a pharmaceutical industry event can be Weve moved toward a contentfirst experience that prioritises s...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Automation Revolution: A Strategic Blueprint for Modern Industrial Production
In the contemporary industrial landscape the fundamental architecture of manufacturing is undergoing a profound and irreversible transformation Historically the strength of an industrial enterprise was often measured by its physical scalespecifically
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro
Iscalimab is a nondepleting antiCD monoclonal antibody expected to suppress immune responses by blocking the costimulation by antigenpresenting cells through CDCDL ligation
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Advertise with Pharma Focus America – Reach America’s Most Influential Pharma Decision Makers
Kate Williamson
The current pharmaceutical and biopharmaceutical environment is very competitive and therefore the ability to cut across the right audience is no longer an option but a strategy. Marketing budgets nee...
-
2
New Drug Development and Clinical Trial Design by Applying Genomic Information Management
Jeong-An Gim
Young Kyung Ko
Depending on the patients’ genotype, the same drug may have different efficacies or side effects. With the cost of genomic analysis decreasing and reliability of analysis methods improving, vast...
-
3
The Chiral Blind Spot: Why AI in Drug Discovery Must Learn to See in 3D
Valliappan Kannappan
Chandramouli Ramnarayanan
AI is rapidly changing Pharma and drug discovery, yet a quiet paradox remains. A molecule’s 3D handedness shapes how it heals or harms, but many advanced models are still effectively stereo-blin...
-
4
Advances and Innovations in Cell and Gene Therapy
Kate Williamson
Modern cell and gene therapy continues to evolve because of three key developments including CRISPR gene editing and mRNA technology within gene therapy as well as CAR-T cell therapy used for autoimmu...
-
5
How to Successfully Enter the American Pharma Market?
Kate Williamson
Entering the North American pharmaceutical market demands a comprehensive strategy. Understanding FDA regulations, conducting thorough market analysis, building strategic partnerships, adapting to hea...
press releasesRead more...
Verista Delivers Comprehensive CSV Services to Ensure Regulatory Compliance and Data Integrity Across the Life Sciences Industry
Verista a leading provider of automation compliance and quality solutions for the life sciences industry highlights their specialized Computer Systems Validation CSV services designed to support
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Eli Lilly and Company NYSE LLY today announced the successful completion of its acquisition of Centessa Pharmaceuticals plc Centessa is a clinicalstage company developing orexin receptor agonists
Verista Highlights COUNTQ® Tray Inspection Systems
Verista a leading provider of automation compliance and quality solutions for the pharmaceutical industry highlights the COUNTQ Tray Inspection System an advanced AIenabled inspection and reconciliation
Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines the Department of Health Abu Dhabi DoH has announced a collaboration with global pharmaceutical
Events Read more...
25 - 26
Jun 2026Pharmacology and Toxicology 2026
Paris, France
07 - 09
Jul 2026The Pharma India Expo 2026
Bombay Exhibition Centre, Mumb...
07 - 09
Jul 2026Nanosciences and Nanotechnologies 2026
Thessaloniki, Greece
08 - 10
Jul 2026CPHI SEA 2026
QSNCC, Bangkok, Thailand
09 - 11
Jul 2026Pharma Pro&Pack Expo 2026
HITEX Exhibition Centre, Hyder...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
LATEST NEWSRead more...
Ionis Gains FDA Approval for TRYNGOLZA to Treat Severe Hypertriglyceridaemia
Ionis Pharmaceuticals has received approval from the US Food and Drug Administration FDA for TRYNGOLZA olezarsen as an addon treatment to diet for adults with severe hypertriglyceridaemia sHTG a condition
Gilead Receives FDA Approval for Trodelvy as First-Line Treatment for Metastatic Triple-Negative Breast Cancer
Gilead Sciences has received approval from the US Food and Drug Administration FDA for Trodelvy sacituzumab govitecanhziy as a firstline treatment for adults with unresectable locally advanced or metastatic
HighRes and Waters Partner to Advance Drug Discovery with Robotic Automation
HighRes has announced a strategic collaboration with Waters Biosciences formerly BD Biosciences to introduce robotic automation capabilities to flow cytometry workflows helping to streamline research activities from basic science to drug discovery
Haisco Grants Nuvectis Global Rights to Two Drug Candidates
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with Nuvectis a US biotechnology company covering two of its internally developed drug candidates for oncology and complementmediated diseases
SystImmune Secures First Approval for Iza-bren to Treat Recurrent or Metastatic Nasopharyngeal Carcinoma in China
SystImmune Inc has announced that its parent company Sichuan Biokin Pharmaceutical Co Ltd has received approval from Chinas National Medical Products Administration NMPA for izabren BLBD
Chai Discovery Partners with Lilly TuneLab to Expand AI Drug Discovery Access for Biotechs
Chai Discovery has partnered with Lilly TuneLab to provide selected biotechnology companies with access to advanced artificial intelligence AI capabilities for earlystage drug discovery
